The Journal of Clinical Medicine is a premier peer-reviewed open-access journal published by MDPI, based in Switzerland. Since its inception in 2012, the journal has carved a niche for itself in the field of medicine, evidenced by its impressive ranking in the 2023 Scopus Ranks, where it stands at #80 out of 636 in General Medicine, placing it in the top 87th percentile. It endeavors to disseminate cutting-edge research that spans various disciplines within medicine, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access available since its launch, the journal ensures that significant medical findings are accessible to a global audience, fostering knowledge exchange and collaboration that is essential in today's rapidly evolving healthcare landscape. The journal's dedication to quality and innovation is further highlighted by its Q1 classification in the 2023 category quartiles for Medicine (miscellaneous), underlining its commitment to advancing clinical knowledge and practice.

SAGE Open Medicine, published by SAGE Publications Inc, stands as an influential open-access journal in the realm of medicine since its inception in 2013. With an ISSN of 2050-3121, this journal facilitates a dynamic platform for the dissemination of rigorous research across a variety of medical disciplines, encompassing extensive topics that range from clinical practice to healthcare policy. Based in the United Kingdom, SAGE Open Medicine has quickly ascended in prominence, achieving a Q2 ranking in the Medicine (miscellaneous) category and securing an impressive placement as #149 out of 636 in the Scopus rankings for general medicine, which places it in the 76th percentile. The journal's commitment to accessibility ensures that researchers, practitioners, and students alike can readily engage with cutting-edge health research that shapes contemporary medical practice. By offering a rigorous peer-review process alongside expedited publication timelines, SAGE Open Medicine remains dedicated to fostering scholarly dialogue and advancing the field of medicine.

BioScience Trends, published by IRCA-BSSA, is a leading academic journal based in Japan that significantly contributes to the fields of biochemistry, genetics, molecular biology, and social health sciences. With an impactful Scopus ranking that places it in the 97th percentile for health social sciences and the 89th percentile for general biochemistry, this journal is an essential resource for researchers and professionals alike. Since its inception in 2007, BioScience Trends has fostered high-quality research dissemination and collaboration, offering a platform for innovative studies and insights that are vital for advancing knowledge in life sciences. Despite being a non-open access publication, it maintains rigorous standards and a reputable presence in the academic community, with an impressive categorization into Q1 and Q2 quartiles as of 2023. Researchers, students, and professionals seeking to stay at the forefront of scientific exploration and health advancements will find BioScience Trends to be an invaluable source for scholarly articles and emerging trends in their respective fields.

Rawal Medical Journal, published by the Pakistan Medical Association, is a prominent academic resource committed to disseminating innovative research in the fields of medicine and nursing. With an ISSN of 0303-5212, this journal serves as a key platform for scholars, practitioners, and students in Pakistan and beyond, contributing to the evolving discourse in healthcare. Although it is currently categorized in the Q4 quartile for both Medicine (miscellaneous) and Nursing (miscellaneous), the journal remains an essential publication for those seeking to enhance their understanding of emerging medical trends and professional practices. Covering research from 2008 to 2024, it aims to foster a collaborative environment for practitioner-oriented and clinical investigations, despite its preliminary ranking in both categories. The journal does not offer Open Access, which invites readers to obtain institutional access or purchase articles directly, ensuring that high-quality research remains accessible to those committed to advancing their knowledge in these vital fields. With its headquarters located at PMA House, Aga Khan III Rd, Karachi, Pakistan, the Rawal Medical Journal is particularly well-situated to address both local and global health challenges.

QJM - An International Journal of Medicine, published by Oxford University Press, stands as a cornerstone in the field of general medicine since its inception in 1907. With an impact factor that places it in the Q2 category of the 2023 Medicine (Miscellaneous) rankings, this journal ranks impressively at #57 out of 636 in its field, placing it within the top 91st percentile on Scopus. This makes it an essential resource for researchers, professionals, and students seeking to stay abreast of the latest findings and developments in the medical domain. Although it does not provide open access options, QJM offers a wealth of critical insights and scholarly articles that contribute significantly to the advancement of medical knowledge and practice. Located in the United Kingdom, it continues to serve as a vital platform for disseminating innovative research and fostering academic discourse across diverse medical specialties.

Einstein-Sao Paulo is a premier open-access journal dedicated to advancing the field of medicine, published by the prestigious INST ISRAELITA ENSINO & PESQUISA ALBERT EINSTEIN in Brazil. Since its inception in 2010, this journal has served as a vital platform for researchers and practitioners alike, fostering the dissemination of groundbreaking studies and innovative healthcare solutions. With an impressive reputation reflected in its Q3 ranking in the category of Medicine (Miscellaneous) and a commendable Scopus rank of #243 out of 636 in general medicine, the journal is positioned as a significant contributor to the global medical research landscape. Its commitment to open access ensures that the latest research is freely available to a wide audience, promoting collaboration and knowledge sharing among professionals. The journal covers a vast array of topics within the medical domain, and its purpose is to bridge the gap between theoretical research and clinical practice, ultimately improving patient care and advancing public health. For researchers, students, and healthcare professionals seeking to stay at the forefront of medical innovation, Einstein-Sao Paulo is an indispensable resource.

Revista del Cuerpo Medico del Hospital Nacional Almanzor Aguinaga Asenjo is a prominent medical journal published by the renowned Hospital Nacional Almanzor Aguinaga Asenjo in Peru. With the ISSN 2225-5109 and E-ISSN 2227-4731, this open-access journal has been serving the medical community since its inception in 2019. It aims to disseminate vital research and insights in the fields of health and medicine, providing a platform for the exchange of knowledge on critical issues affecting public health and healthcare policy in Latin America. Although classified in the Q4 category for both Health (social science) and Medicine (miscellaneous) in 2023, its essential contributions to health professions and policy add significant value to researchers and practitioners alike. Positioned within the context of a rapidly evolving healthcare landscape, the journal is crucial for fostering a better understanding of the challenges and innovations in healthcare delivery and medical practice. Researchers, professionals, and students looking to deepen their understanding of these fields will find this journal invaluable as it continues to grow and adapt through 2024 and beyond.

ANNALS OF MEDICINE, published by Taylor & Francis Ltd, stands as a leading journal in the field of medical research, holding a prestigious Q1 ranking within the miscellaneous medicine category as of 2023. With a focus on disseminating high-quality, peer-reviewed research, the journal provides a vital platform for scholars, clinicians, and policy-makers to share innovative findings that advance the understanding and practice of medicine. Established in 1961, ANNALS OF MEDICINE has continuously evolved, promoting interdisciplinary approaches and fostering collaboration among researchers across various medical specialties. Its impressive Scopus rank of #103 out of 636, representing the top 83rd percentile in general medicine, underscores its influence and importance in the medical community. Although it does not offer Open Access options, the journal remains committed to maintaining rigorous academic standards, making it an essential resource for anyone dedicated to improving healthcare outcomes through scholarly research.

Welcome to Advances in Clinical and Experimental Medicine, an esteemed publication by WROCLAW MEDICAL UNIVERSITY, dedicated to advancing the essential fields of clinical and experimental medicine. With an open access model since 2017, this journal ensures that researchers, healthcare professionals, and students worldwide can freely access high-quality scientific content. Covering a broad spectrum of topics including biochemistry, genetics, internal medicine, and pharmacology, Advances in Clinical and Experimental Medicine has established itself as a pivotal resource in the scientific community, currently holding prestigious rankings such as Q2 in Biochemistry, Genetics, and Molecular Biology (miscellaneous) and Q1 in Reviews and References (medical) for 2023. Spanning over two decades of rigorous research publication, the journal is a critical platform for sharing innovative findings and fostering collaboration among scholars, making it an invaluable asset for those at the forefront of medical science.

European Journal of Therapeutics is a distinguished journal dedicated to advancing the field of therapeutic sciences through high-quality research and innovative clinical practice. Published by Pera Yayincilik Hizmetleri, this interdisciplinary journal aims to facilitate knowledge dissemination in areas such as pharmacology, clinical medicine, and public health, thereby supporting both researchers and practitioners in improving therapeutic outcomes. Although the journal operates under a subscription model, its commitment to rigorous peer review ensures that published articles reflect the latest advancements and methodologies. With a growing emphasis on evidence-based therapies, the European Journal of Therapeutics serves as a vital platform for dialogue among healthcare professionals and researchers, enhancing the understanding of therapeutic interventions on a global scale. It welcomes contributions ranging from original research to review articles, making it an essential resource for those seeking to enrich their knowledge and influence practice in therapeutic approaches.